Innocare Pharma

InnoCare Pharma is a leading biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for cancer and autoimmune diseases. Founded in 2015 and headquartered in Beijing, China, the company leverages cutting-edge research in small molecule drugs and immunotherapy to address unmet medical needs. InnoCare generates revenue through the development, licensing, and commercialization of its proprietary drug pipeline, with notable products like orelabrutinib, a BTK inhibitor for treating B-cell malignancies and autoimmune disorders. Its commitment to innovation and strategic global partnerships has positioned it as a key player in the biotech industry, particularly in the Asia-Pacific region.

Recent Posts by Innocare Pharma

1-20 of 73